Dr. Reddy's Labs Recalls Levetiracetam In Sodium Chloride Injection

RTTNews | 223天前
Dr. Reddy's Labs Recalls Levetiracetam In Sodium Chloride Injection

(RTTNews) - Dr. Reddy's Laboratories Ltd. is recalling select Levetiracetam in Sodium Chloride Injection in the United States citing mislabeling of infusion bag, according to the U.S. Food and Drug Administration.

The recall involves one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL (10 mg/mL) single-dose infusion bags to the consumer level.

The infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL single-dose bag, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL.

Both Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL and Levetiracetam in 0.82% Sodium Chloride Injection, 500 mg/100 mL are indicated for adjunct therapy in adults with select seizure types when oral administration is temporarily not feasible.

When administered the mislabeled product, the patient could receive double the dose of intravenous levetiracetam than intended as the infusion bag is labelled as 500 mg/100 mL but actually contains 1,000 mg/100 mL dose. Such patients are likely to experience adverse events, leading to immediate and serious side effects. These include hypersensitivity reactions, liver injury, hematological toxicity, somnolence, fatigue, dizziness, coordination difficulties, agitation, aggression, depressed level of consciousness, respiratory depression, and coma.

The FDA noted that patients receiving high doses of levetiracetam by rapid intravenous infusion for the treatment of status epilepticus would be most at risk for severe adverse events.

However, Dr. Reddy's has not received any reports of adverse events related to the recalled product so far.

The recall involves Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, packaged in single-dose infusion bags with an aluminum overwrap, 10 single-dose bags packed in a carton.

The mislabelled bags come with NDC numbers 43598-635-52 and 43598-636-52, with Lot Number A1540076 and Expiration Date of 08/2026. The carton holds NDC number 43598-636-10. The batch was distributed nationwide between November 4, 2024, and November 6, 2024, to wholesalers.

Dr. Reddy's is notifying its distributors and customers to arrange for return of any recalled product. Wholesalers, distributors, hospitals, and pharmacies with an existing inventory of the impacted lot are asked to stop use and distribution and quarantine the product immediately for return/replacement.

Dr. Reddy's last year had called back six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level, due to powder discoloration in some packets leading to decreased potency.

For More Such Health News, visit rttnews.com

read more
Dr. Reddy's Recalls Sapropterin Dihydrochloride Powder For Oral Solution

Dr. Reddy's Recalls Sapropterin Dihydrochloride Powder For Oral Solution

Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.
RTTNews | 547天前
Sensex, Nifty Open On Buoyant Note Amid Trade Deal Hopes

Sensex, Nifty Open On Buoyant Note Amid Trade Deal Hopes

Indian shares opened on a buoyant note on Thursday after reports suggested that India and the United States are close to finalizing a long-awaited bilateral trade deal that could sharply lower tariffs on Indian exports to about 15-16 percent from the current average of 50 percent.
RTTNews | 9分鐘前
Australian Market Swings To Modest Gains In Mid-market

Australian Market Swings To Modest Gains In Mid-market

The Australian market is swinging to modest gains in mid-market moves on Thursday, reversing some of the losses in the previous two sessions, despite the broadly negative cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying well above the 9,000 mark, with gains in gold miners and energy stocks partially offset by weakness in iron ore miners, financial and technology stocks.
RTTNews | 1小時6分鐘前
Asian Markets Trade Mostly Higher

Asian Markets Trade Mostly Higher

Asian markets are trading mostly higher on Thursday, despite the broadly negative cues from Wall Street overnight, amid optimism about the outlook for interest rates as markets are pricing in another rate cut by the U.S. Fed at its upcoming October 28-29 monetary policy meeting, despite the absence of vital data to gauge the trajectory of the economy. Asian markets closed mostly lower on Wednesday
RTTNews | 1小時14分鐘前
Japanese Market Sharply Lower

Japanese Market Sharply Lower

The Japanese market is sharply lower on Thursday, extending the losses in the previous session, following the broadly negative cues from Wall Street overnight. The Nikkei 225 is falling well below the 48,700 level, with weakness across most sectors led by index heavyweights and technology stocks.
RTTNews | 3小時2分鐘前
Indonesia Stock Market May Extend Wednesday's Losses

Indonesia Stock Market May Extend Wednesday's Losses

The Indonesia stock market on Wednesday snapped the two-day winning streak in which it had jumped more than 310 points or 3.9 percent along the way. The Jakarta Composite Index now rests just above the 8,150-point plateau and it's likely to open in the red again on Thursday.
RTTNews | 3小時4分鐘前
Lower Open Predicted For Hong Kong Stock Market

Lower Open Predicted For Hong Kong Stock Market

The Hong Kong stock market on Wednesday ended the two-day winning streak in which it had picked up more than 775 points or 2.8 percent. The Hang Seng Index now rests just above the 25,780-point plateau and it's looking at another soft start again on Thursday.
RTTNews | 3小時19分鐘前